Abstract
Introduction

Acute tumor lysis syndrome (ATLS) is a well-recognized complication that usually follows chemotherapy for rapidly proliferating neoplasms. ATLS is characterized by hyperphosphatemia, hypocalcemia, hyperuricemia and hyperkalemia and can lead rapidly to an acute renal failure
. Although ATLS has been commonly described after systemic cytotoxic chemotherapy, it has been reported in only 2 patients after intrathecal chemotherapy (2, 3 
Discussion
To the best of our knowledge, this is the third case of ATLS to be described following intrathecal chemotherapy. The systemic effect of intrathecal chemotherapy has been reported. The anatomic relationship between the medulla spinalis and the bone marrow is likely to provide major part of the cerebrospinal fluid (CSF) transportion to the systemic circulation (4, 5) . Methotrexate is not metabolized in the CSF and released into the systemic circulation with prolonged cytotoxic levels (3, 6 
